Faysal Yousefi, MD | |
229 N Pecos Rd Ste 120, Henderson, NV 89074-7364 | |
(702) 629-7510 | |
Not Available |
Full Name | Faysal Yousefi |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 22 Years |
Location | 229 N Pecos Rd Ste 120, Henderson, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366642191 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 243240-1 (New York) | Secondary |
207RN0300X | Internal Medicine - Nephrology | 20624 (Nevada) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Rose Dominican Hospitals - Siena Campus | Henderson, NV | Hospital |
Sanford Medical Center Fargo | Fargo, ND | Hospital |
Henderson Hospital | Henderson, NV | Hospital |
Essentia Health | Fargo, ND | Hospital |
Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Duluth Clinic Ltd | 2567374283 | 932 |
Innovis Health Llc | 9931298155 | 473 |
Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Researchers at University of Utah Health have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for two new indications for collection of plasma products on the Fenwal Alyx and Amicus systems.
› Verified 5 days ago
Entity Name | The Duluth Clinic Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Researchers at University of Utah Health have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for two new indications for collection of plasma products on the Fenwal Alyx and Amicus systems.
› Verified 5 days ago
Entity Name | Sanford Health Of Northern Minnesota |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770849697 PECOS PAC ID: 5597725168 Enrollment ID: O20041025000442 |
News Archive
Researchers at University of Utah Health have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for two new indications for collection of plasma products on the Fenwal Alyx and Amicus systems.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Faysal Yousefi, MD 3022 S Durango Dr Ste 100, Las Vegas, NV 89117-4440 Ph: (702) 256-3637 | Faysal Yousefi, MD 229 N Pecos Rd Ste 120, Henderson, NV 89074-7364 Ph: (702) 629-7510 |
News Archive
Researchers at University of Utah Health have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.
In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for two new indications for collection of plasma products on the Fenwal Alyx and Amicus systems.
› Verified 5 days ago
James B Gabroy, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1535 West Warm Spring Road, Suite 135, Henderson, NV 89014 Phone: 702-450-3385 Fax: 702-898-1699 | |
Dr. Poupak Ziaei, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2641 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-616-0091 Fax: 702-616-2329 | |
Dr. Jeannette Nee, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2865 Siena Heights Dr, Suite 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Wen Liang, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2621 W Horizon Ridge Pkwy, Suite 150, Henderson, NV 89052 Phone: 702-837-6368 Fax: 702-837-0685 | |
Randy James Ip, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Linda Lou Johnson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1501 W Sunset Rd, Henderson, NV 89014 Phone: 725-269-7001 Fax: 725-269-7003 | |
Dr. Daejoon Anh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 |